Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Rheumatology

Vall Hebron Institut de Recerca

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Rheumatology

Vall Hebron Institut de Recerca

Related news

Formation Bio Licenses First-in-Class Anti-CD226 Autoimmune Program from IMIDomics

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

Strong presence of VHIR at the European Alliance of Associations for Rheumatology Congress

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Vall d'Hebron hosts the general assembly of the European project DocTIS

Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs